Making use of various information systems to disseminate HTA

knowledge in France

Illustrations in complement to the poster

HTAi June 2015, Oslo

Hervé Nabarette, Olivier Meignen, Pierre Liot, Sorin Stanel, Nathalie Merle

French National Authority for Health (HAS)

June 2015 1

2

Various informations systems to disseminate HTA knowledge in France

June 2015 Making use of various information systems to disseminate HTA knowlege in France

Adapting to Internet trends and development

– Search engine optimization

– Newsletter subscription

– Social media

– HAS’ Website Mobile Version ILLUSTRATION

Capitalizing on the use of the public body drug database ILLUSTRATION

Capitalizing on the use of prescription software

3

HAS’ Website Mobile Version

June 2015 Making use of various information systems to disseminate HTA knowlege in France

Dedicated entry for drugs and devices

The public body drug database : a way to disseminate HTA information

The database collects basic information from various sources.

Public body drug

database

The National Security Agency of Medicines and Health Products

(ANSM)

The French National Authority for Health

(HAS) HTA information

National Health Insurance

The Ministry of Health

4June 2015 Making use of various information systems to disseminate HTA knowlege in France

The public body drug database : a way to disseminate HTA information

5June 2015 Making use of various information systems to disseminate HTA knowlege in France

Entry by brand name or active ingredient

The public body drug database : a way to disseminate HTA information

6June 2015 Making use of various information systems to disseminate HTA knowlege in France

Two other tabs: summary of the

product characteristics,

patient monograph

Important information = current safety

topics

Main tab

The public body drug database : a way to disseminate HTA information

7June 2015 Making use of various information systems to disseminate HTA knowlege in France

Therapeutic indications

Product packaging

Drug pricing

Ingredients

Generic drugs

(…)

Main tab (top of page)

The public body drug database : a way to disseminate HTA information

8June 2015 Making use of various information systems to disseminate HTA knowlege in France

HTA assessment report and summary report (link)

HTA document about appropriate use (link)

Actual Benefit indicator (HTA data)

Main tab (middle of page)

The public body drug database : a way to disseminate HTA information

9June 2015 Making use of various information systems to disseminate HTA knowlege in France

Improvement in Actual Benefit indicator (HTA data)

Main tab (bottom of page)

The public body drug database : a way to disseminate HTA information

10June 2015 Making use of various information systems to disseminate HTA knowlege in France

Modality of transmission (technical IT aspects)

HTA data : extracted from HAS’ internal IT system, with the identifiers of corresponding drugs. Lines of transmitted information:

3400935931016 ; LIPOSIC 2 mg/g, gel ophtalmique; 23/07/2014 ; SMR Important ; (…)

HTA documents : HAS transmits the Web addresses (links) and the identifiers of concerned drugs. Lines of transmitted information:

65411280 ; 11/09/2013 ; Traitement de la dépression : quelle place pour la tianeptine

(Stablon®) ? ; http://www.has-sante.fr/portail/jcms/c_1637734 (...)

60660018 ; 11/09/2013 ; Traitement de la dépression : quelle place pour la tianeptine

(Stablon®) ? ; http://www.has-sante.fr/portail/jcms/c_1637734 (...)

NB : HAS also provides this data via « open data »